Anne Lesage, Chief Early Development at Pharvaris N.V. (PHVS), sold 30,000 shares at $38.30 ($1.1M) on 2026-09-10, disclosed to the SEC on 2026-09-14.
Scheduled sale ($1.1M) by Chief Early Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PHVS | SELL | 2026-06-29 | $162K | — | Filing → |
| PHVS | SELL | 2026-05-01 | $1.5M | — | Filing → |
| PHVS | SELL | 2026-04-24 | $439K | — | Filing → |